10-K – Annual report [Section 13 and 15(d), not S-K Item 405]

Protalix has filed a 10-K – Annual report [Section 13 and 15(d), not S-K Item 405] with the U.S. Securities and Exchange Commission .

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Aptose to Participate in Upcoming Investor Conferences In March 2018

On March 6, 2018 Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, reported that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the upcoming conferences (Press release, Aptose Biosciences, MAR 6, 2018, View Source;p=RssLanding&cat=news&id=2336407 [SID1234524433]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 38th Annual Healthcare Conference
Time: 12:00 p.m. EDT
Date: Monday, March 12, 2018
Location: The Boston Marriott Copley Place, Boston, MA
Live webcast: http://wsw.com/webcast/cowen46/apto/

30th Annual ROTH Conference
Time: 9:30 a.m. PDT
Date: Tuesday, March 13, 2018
Location: The Ritz Carlton, Laguna Niguel, CA
Live webcast: View Source

2018 B. Riley & Co. China Healthcare Investment Partnering Symposium
Time: 11:30 a.m. CST (China Standard Time)
Date: Friday, March 16, 2018
Location: The Intercontinental Hotel, Hangzhou, People’s Republic of China
Live webcast: View Source

Oppenheimer 28th Annual Healthcare Conference
Time: 8:00 a.m. EDT
Date: Wednesday, March 21, 2018
Location: The Westin Grand Central, New York, NY
Live webcast: https://veracast.com/webcasts/opco/healthcare2018/76201109497.cfm

The audio webcasts can also be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live event and available for 90 days.

Kura Oncology to Present at Cowen and Company 38th Annual Health Care Conference

On March 6, 2018 Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, reported its participation in the Cowen and Company 38th Annual Health Care Conference. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to present an overview of the company on Tuesday, March 13, 2018 at 8:40 a.m. ET / 5:40 a.m. PT (Press release, Kura Oncology, MAR 6, 2018, http://ir.kuraoncology.com/news-releases/news-release-details/kura-oncology-present-cowen-and-company-38th-annual-health-care [SID1234524453]). The conference will be held from March 12-14, 2018 in Boston.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be available in the Investors section of Kura Oncology’s website at www.kuraoncology.com, with an archived replay available for 30 days following the event.

Five Prime Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference

On March 6, 2018 Five Prime Therapeutics, Inc. (Nasdaq: FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, reported that Aron Knickerbocker, Chief Executive Officer, will present at the Cowen and Company 38th Annual Health Care Conference, March 12, 2018, at 11:20 am ET (Press release, Five Prime Therapeutics, MAR 6, 2018, http://investor.fiveprime.com/news-releases/news-release-details/five-prime-therapeutics-present-cowen-and-company-38th-annual [SID1234524645]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast and may be accessed at the "Events & Presentations" section of the Company’s website at View Source Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

10-K – Annual report [Section 13 and 15(d), not S-K Item 405]

Fate Therapeutics has filed a 10-K – Annual report [Section 13 and 15(d), not S-K Item 405] with the U.S. Securities and Exchange Commission (Filing, 10-K, Fate Therapeutics, 2018, MAR 5, 2018, View Source [SID1234524403]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!